Article Details
Retrieved on: 2024-12-20 23:39:19
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the importance of Contract Development and Manufacturing Organizations (CDMOs) in the biopharma sector, highlighting key players like Catalent and WuXi AppTec that support advancements in gene therapy, antibody-drug conjugates, and antineoplastic drugs.
Article found on: www.biopharminternational.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here